Paper Details

  1. Home
  2. Paper Details

Delgocitinib in atopic dermatitis.

Author: HoJ, MolinS

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Delgocitinib ointment, the first topical JAK inhibitor approved for atopic dermatitis (AD), offers a promising treatment option with a favorable safety profile. Further research is needed to explore its long-term efficacy and optimal usage.
Paper Details　
Original Abstract of the Article :
Delgocitinib ointment is a newly approved topical medication for the treatment of atopic dermatitis (AD). AD usually has onset in early childhood and is a common, often chronic relapsing inflammatory skin condition that affects all age groups. AD has a large impact on patients' quality of life inclu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1358/dot.2021.57.12.3352760

データ提供：米国国立医学図書館（NLM）

Delgocitinib: A New Era in Atopic Dermatitis Treatment

This review explores the potential of delgocitinib, a newly approved topical medication for the treatment of atopic dermatitis (AD). The authors provide a comprehensive overview of delgocitinib's preclinical pharmacology, pharmacokinetics and metabolism, safety, existing clinical trials, and future directions. This review highlights delgocitinib's potential as a novel and effective treatment for AD, offering a new perspective on managing this common and often debilitating skin condition.

Delgocitinib: A Promising Weapon in the Fight Against Atopic Dermatitis

This review sheds light on the potential of delgocitinib, a newly approved topical medication for the treatment of atopic dermatitis (AD). The authors highlight the efficacy and safety of delgocitinib, suggesting that it could become a valuable treatment option for those suffering from AD. This is particularly encouraging given the limitations of current treatment options for this chronic and often debilitating skin condition.

Navigating the Sands of Atopic Dermatitis: Seeking New Solutions

Atopic dermatitis (AD) can significantly impact quality of life. This review explores the potential of delgocitinib, a new topical JAK inhibitor, as a promising treatment option for AD. The authors highlight delgocitinib's efficacy and safety, suggesting that it could become a valuable addition to the therapeutic arsenal for managing this common and often debilitating skin condition. Further research is needed to fully understand the long-term effects of delgocitinib and to optimize its use in clinical practice, but these findings offer hope for a more effective and sustainable treatment for AD.

Dr.Camel's Conclusion

Delgocitinib is a promising new topical medication for the treatment of atopic dermatitis (AD). The research suggests that it is effective, safe, and could be a valuable addition to the current treatment options for this challenging skin condition. Further research is needed to fully understand its long-term effects and optimize its use in clinical practice, but these findings offer hope for a more effective and sustainable treatment for AD.
Date :
  1. Date Completed 2021-12-17
  2. Date Revised 2021-12-17
Further Info :

Pubmed ID

34909801

DOI: Digital Object Identifier

10.1358/dot.2021.57.12.3352760

Related Literature

Article Analysis
・Effects of pimecrolimus topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.